These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 21151031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. National Institutes of Health. A government niche for translational medicine and drug development.
    Kaiser J.
    Science; 2010 Dec 10; 330(6010):1462-3. PubMed ID: 21148358
    [No Abstract] [Full Text] [Related]

  • 3. Leveraging public private partnerships to innovate under challenging budget times.
    Portilla LM, Rohrbaugh ML.
    Curr Top Med Chem; 2014 Dec 10; 14(3):326-9. PubMed ID: 24283971
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Re-engineering drug discovery and development.
    FitzGerald GA.
    LDI Issue Brief; 2011 Oct 10; 17(2):1-4. PubMed ID: 22049582
    [Abstract] [Full Text] [Related]

  • 7. NerveCenter: At a glance: NIH programs supporting translational research in neurological disease.
    Ann Neurol; 2010 Sep 10; 68(3):A9. PubMed ID: 20818783
    [No Abstract] [Full Text] [Related]

  • 8. NIH encourages translational collaboration with industry.
    Wadman M.
    Nat Rev Drug Discov; 2010 Apr 10; 9(4):255-6. PubMed ID: 20224566
    [No Abstract] [Full Text] [Related]

  • 9. Drug development needs a new brand of science.
    Fitzgerald G.
    Nature; 2010 Dec 16; 468(7326):869. PubMed ID: 21164436
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T, Gatenbeck L.
    Lakartidningen; 2010 Dec 16; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Into the valley of death: research to innovation.
    Hudson J, Khazragui HF.
    Drug Discov Today; 2013 Jul 16; 18(13-14):610-3. PubMed ID: 23402848
    [Abstract] [Full Text] [Related]

  • 16. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
    Rai AK, Reichman JH, Uhlir PF, Crossman C.
    Yale J Health Policy Law Ethics; 2008 Jul 16; 8(1):1-36. PubMed ID: 18564492
    [No Abstract] [Full Text] [Related]

  • 17. Outcry over plans for 'Japanese NIH'.
    Fuyuno I.
    Nature; 2013 Jul 11; 499(7457):136-7. PubMed ID: 23846639
    [No Abstract] [Full Text] [Related]

  • 18. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M, Chaguturu R.
    Expert Opin Drug Discov; 2017 Jun 11; 12(6):537-540. PubMed ID: 28394189
    [No Abstract] [Full Text] [Related]

  • 19. Newsmaker interview. Francis Collins: on recruiting Varmus, discovering drugs, the funding cliff. Interview by Jocelyn Kaiser.
    Collins F.
    Science; 2010 May 28; 328(5982):1090-1. PubMed ID: 20508101
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.